Related Experiment Video
Updated: Jul 13, 2026
06:08
Design of Solid-State Fermentation Systems for Polymer Hydrolytic Extracellular Enzyme Production by Filamentous Fungi
Published on: June 6, 2025
An integrated approach to developing chemoenzymatic processes at the industrial scale.
Ernst Schering Foundation Symposium Proceedings
|August 19, 2007
Summary
Biocatalysis, using engineered enzymes, offers a powerful approach for sustainable chemical synthesis. Integrating biotransformations with chemical methods enables cost-effective and eco-friendly drug manufacturing.
Area of Science:
- Biocatalysis and chemoenzymatic synthesis in pharmaceutical manufacturing.
Background:
- Biocatalysis is a rapidly advancing field driven by innovations in enzyme discovery, protein engineering, and screening technologies.
- Integrating biocatalysis with traditional chemical synthesis is crucial for developing efficient and sustainable industrial processes.
Purpose of the Study:
- To illustrate the application of chemoenzymatic synthesis in producing pharmaceutical ingredients.
- To highlight the integration of biotransformations and chemical R&D for industrial drug manufacture.
Main Methods:
- Utilizing advances in enzyme discovery and engineering.
- Applying high-throughput screening and enzyme evolution techniques.
- Integrating biocatalysis with chemical synthesis strategies.
Main Results:
- Demonstrated successful chemoenzymatic synthesis of active pharmaceutical ingredients and intermediates.
- Showcased the development of cost-effective and environmentally friendly manufacturing solutions.
- Illustrated the practical application of integrated biocatalysis in the pharmaceutical industry.
Conclusions:
- Biocatalysis is a transformative technology for chemical synthesis.
- The integration of biocatalysis and chemical synthesis is key to sustainable drug manufacturing.
- Chemoenzymatic approaches offer efficient and green solutions for pharmaceutical production.
Related Concept Videos
01:14Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:27Production of Alcohol
Continuous fermentation is a key strategy in industrial ethanol production, particularly when efficiency, scalability, and high yields are essential. This approach allows for uninterrupted operation and optimized resource utilization. The primary feedstock, corn starch, undergoes enzymatic hydrolysis facilitated by α-amylase and glucoamylase. These enzymes break down the starch into fermentable sugars such as glucose, which are readily assimilated by fermentative microorganisms.Fermentation...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...